Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

The nucleus does not significantly affect the migratory trajectories of amoeba in two-dimensional environments.

De la Fuente IM, Bringas C, Malaina I, Regner B, Pérez-Samartín A, Boyano MD, Fedetz M, López JI, Pérez-Yarza G, Cortes JM, Sejnowski T.

Sci Rep. 2019 Nov 8;9(1):16369. doi: 10.1038/s41598-019-52716-2.

2.

Evidence of conditioned behavior in amoebae.

De la Fuente IM, Bringas C, Malaina I, Fedetz M, Carrasco-Pujante J, Morales M, Knafo S, Martínez L, Pérez-Samartín A, López JI, Pérez-Yarza G, Boyano MD.

Nat Commun. 2019 Aug 15;10(1):3690. doi: 10.1038/s41467-019-11677-w.

3.

Imaging Mass Spectrometry-Based Lipidomic Approach to Classification of Architectural Features in Nevi.

Garate J, Lage S, Fernández R, Velasco V, Abad B, Asumendi A, Gardeazabal J, Arroyo-Berdugo Y, Rodríguez MÁ, Artola JL, Zabalza I, Ochoa B, Fernández JA, Boyano MD.

J Invest Dermatol. 2019 Sep;139(9):2055-2058.e7. doi: 10.1016/j.jid.2019.01.031. Epub 2019 Mar 13. No abstract available.

PMID:
30878679
4.

Cost-Effective Design of High-Magnetic Moment Nanostructures for Biotechnological Applications.

Mora B, Perez-Valle A, Redondo C, Boyano MD, Morales R.

ACS Appl Mater Interfaces. 2018 Mar 7;10(9):8165-8172. doi: 10.1021/acsami.7b16779. Epub 2018 Feb 21.

PMID:
29390182
5.

Identification of a panel of serum protein markers in early stage of sepsis and its validation in a cohort of patients.

Garcia-Obregon S, Azkargorta M, Seijas I, Pilar-Orive J, Borrego F, Elortza F, Boyano MD, Astigarraga I.

J Microbiol Immunol Infect. 2018 Aug;51(4):465-472. doi: 10.1016/j.jmii.2016.12.002. Epub 2017 Jun 13.

6.

Dynamic properties of calcium-activated chloride currents in Xenopus laevis oocytes.

M De la Fuente I, Malaina I, Pérez-Samartín A, Boyano MD, Pérez-Yarza G, Bringas C, Villarroel Á, Fedetz M, Arellano R, Cortes JM, Martínez L.

Sci Rep. 2017 Feb 13;7:41791. doi: 10.1038/srep41791.

7.

Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I-II early-stage melanoma.

Ortega-Martínez I, Gardeazabal J, Erramuzpe A, Sanchez-Diez A, Cortés J, García-Vázquez MD, Pérez-Yarza G, Izu R, Luís Díaz-Ramón J, de la Fuente IM, Asumendi A, Boyano MD.

Int J Cancer. 2016 Oct 1;139(7):1598-607. doi: 10.1002/ijc.30202. Epub 2016 Jun 11.

8.

Sex-specific genetic effects associated with pigmentation, sensitivity to sunlight, and melanoma in a population of Spanish origin.

Hernando B, Ibarrola-Villava M, Fernandez LP, Peña-Chilet M, Llorca-Cardeñosa M, Oltra SS, Alonso S, Boyano MD, Martinez-Cadenas C, Ribas G.

Biol Sex Differ. 2016 Mar 18;7:17. doi: 10.1186/s13293-016-0070-1. eCollection 2016.

9.

Metformin Induces Cell Cycle Arrest and Apoptosis in Drug-Resistant Leukemia Cells.

Rodríguez-Lirio A, Pérez-Yarza G, Fernández-Suárez MR, Alonso-Tejerina E, Boyano MD, Asumendi A.

Leuk Res Treatment. 2015;2015:516460. doi: 10.1155/2015/516460. Epub 2015 Nov 25.

10.

Comparison of the Transcriptional Profiles of Melanocytes from Dark and Light Skinned Individuals under Basal Conditions and Following Ultraviolet-B Irradiation.

López S, Smith-Zubiaga I, García de Galdeano A, Boyano MD, García O, Gardeazábal J, Martinez-Cadenas C, Izagirre N, de la Rúa C, Alonso S.

PLoS One. 2015 Aug 5;10(8):e0134911. doi: 10.1371/journal.pone.0134911. eCollection 2015.

11.

The interplay between natural selection and susceptibility to melanoma on allele 374F of SLC45A2 gene in a South European population.

López S, García O, Yurrebaso I, Flores C, Acosta-Herrera M, Chen H, Gardeazabal J, Careaga JM, Boyano MD, Sánchez A, Ratón-Nieto JA, Sevilla A, Smith-Zubiaga I, de Galdeano AG, Martinez-Cadenas C, Izagirre N, de la Rúa C, Alonso S.

PLoS One. 2014 Aug 5;9(8):e104367. doi: 10.1371/journal.pone.0104367. eCollection 2014.

12.

Involvement of ANXA5 and ILKAP in susceptibility to malignant melanoma.

Arroyo-Berdugo Y, Alonso S, Ribas G, Ibarrola-Villava M, Peña-Chilet M, Martínez-Cadenas C, Gardeazabal J, Ratón-Nieto JA, Sánchez-Díez A, Careaga JM, Pérez-Yarza G, Carretero G, Martín-González M, Gómez-Fernández C, Nagore E, Asumendi A, Boyano MD.

PLoS One. 2014 Apr 17;9(4):e95522. doi: 10.1371/journal.pone.0095522. eCollection 2014.

13.

Dihydroceramide accumulation and reactive oxygen species are distinct and nonessential events in 4-HPR-mediated leukemia cell death.

Apraiz A, Idkowiak-Baldys J, Nieto-Rementería N, Boyano MD, Hannun YA, Asumendi A.

Biochem Cell Biol. 2012 Apr;90(2):209-23. doi: 10.1139/o2012-001. Epub 2012 Mar 19.

14.

Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells.

Apraiz A, Idkowiak-Baldys JK, Boyano MD, Pérez-Yarza G, Hannun YA, Asumendi A.

BMC Cancer. 2011 Nov 7;11:477. doi: 10.1186/1471-2407-11-477.

15.

Terfenadine induces apoptosis and autophagy in melanoma cells through ROS-dependent and -independent mechanisms.

Nicolau-Galmés F, Asumendi A, Alonso-Tejerina E, Pérez-Yarza G, Jangi SM, Gardeazabal J, Arroyo-Berdugo Y, Careaga JM, Díaz-Ramón JL, Apraiz A, Boyano MD.

Apoptosis. 2011 Dec;16(12):1253-67. doi: 10.1007/s10495-011-0640-y.

16.

A customized pigmentation SNP array identifies a novel SNP associated with melanoma predisposition in the SLC45A2 gene.

Ibarrola-Villava M, Fernandez LP, Alonso S, Boyano MD, Peña-Chilet M, Pita G, Aviles JA, Mayor M, Gomez-Fernandez C, Casado B, Martin-Gonzalez M, Izagirre N, De la Rua C, Asumendi A, Perez-Yarza G, Arroyo-Berdugo Y, Boldo E, Lozoya R, Torrijos-Aguilar A, Pitarch A, Pitarch G, Sanchez-Motilla JM, Valcuende-Cavero F, Tomas-Cabedo G, Perez-Pastor G, Diaz-Perez JL, Gardeazabal J, Martinez de Lizarduy I, Sanchez-Diez A, Valdes C, Pizarro A, Casado M, Carretero G, Botella-Estrada R, Nagore E, Lazaro P, Lluch A, Benitez J, Martinez-Cadenas C, Ribas G.

PLoS One. 2011 Apr 29;6(4):e19271. doi: 10.1371/journal.pone.0019271.

17.

Cell-centric view of apoptosis and apoptotic cell death-inducing antitumoral strategies.

Apraiz A, Boyano MD, Asumendi A.

Cancers (Basel). 2011 Mar 3;3(1):1042-80. doi: 10.3390/cancers3011042.

18.

Histamine and histamine receptor antagonists in cancer biology.

Blaya B, Nicolau-Galmés F, Jangi SM, Ortega-Martínez I, Alonso-Tejerina E, Burgos-Bretones J, Pérez-Yarza G, Asumendi A, Boyano MD.

Inflamm Allergy Drug Targets. 2010 Jul;9(3):146-57. Review.

PMID:
20632959
19.

The diversity profile of TP53 is influenced by positive selection on the immediately upstream locus WDR79.

Alonso S, Izagirre N, López S, Smith-Zubiaga I, Hervella M, Boyano MD, Arroyo-Berdugo Y, Gardeazabal J, Díaz-Ramón JL, Sánchez Díez A, Careaga JM, de la Rúa C.

Hum Hered. 2010;69(1):34-44. doi: 10.1159/000243152. Epub 2009 Oct 2.

20.

Plasma membrane and nuclear envelope integrity during the blebbing stage of apoptosis: a time-lapse study.

Andrade R, Crisol L, Prado R, Boyano MD, Arluzea J, Aréchaga J.

Biol Cell. 2009 Oct 12;102(1):25-35. doi: 10.1042/BC20090077.

PMID:
19630753
21.

Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma.

Nieto-Rementería N, Pérez-Yarza G, Boyano MD, Apraiz A, Izu R, Díaz-Pérez JL, Asumendi A.

Br J Dermatol. 2009 Mar;160(3):519-26. doi: 10.1111/j.1365-2133.2008.08931.x. Epub 2008 Nov 25.

PMID:
19067706
22.

Imprinting of mammalian male gametes is gene specific and does not occur at a single stage of differentiation.

Boyano MD, Andollo N, Zalduendo MM, Aréchaga J.

Int J Dev Biol. 2008;52(8):1105-11. doi: 10.1387/ijdb.072284mb.

23.

Complex signatures of selection for the melanogenic loci TYR, TYRP1 and DCT in humans.

Alonso S, Izagirre N, Smith-Zubiaga I, Gardeazabal J, Díaz-Ramón JL, Díaz-Pérez JL, Zelenika D, Boyano MD, Smit N, de la Rúa C.

BMC Evol Biol. 2008 Feb 29;8:74. doi: 10.1186/1471-2148-8-74.

24.

Terfenadine-induced apoptosis in human melanoma cells is mediated through Ca2+ homeostasis modulation and tyrosine kinase activity, independently of H1 histamine receptors.

Jangi SM, Ruiz-Larrea MB, Nicolau-Galmés F, Andollo N, Arroyo-Berdugo Y, Ortega-Martínez I, Díaz-Pérez JL, Boyano MD.

Carcinogenesis. 2008 Mar;29(3):500-9. doi: 10.1093/carcin/bgm292. Epub 2008 Jan 3.

PMID:
18174239
25.

Interleukin-2 induces the proliferation of mouse primordial germ cells in vitro.

Eguizabal C, Boyano MD, Díez-Torre A, Andrade R, Andollo N, De Felici M, Aréchaga J.

Int J Dev Biol. 2007;51(8):731-8.

26.

4-HPR-mediated leukemia cell cytotoxicity is triggered by ceramide-induced mitochondrial oxidative stress and is regulated downstream by Bcl-2.

Morales MC, Pérez-Yarza G, Rementería NN, Boyano MD, Apraiz A, Gómez-Muñoz A, Pérez-Andrés E, Asumendi A.

Free Radic Res. 2007 May;41(5):591-601.

PMID:
17454142
27.

Epigenetic regulation of the imprinted U2af1-rs1 gene during retinoic acid-induced differentiation of embryonic stem cells.

Andollo N, Boyano MD, Andrade R, Aréchaga JM.

Dev Growth Differ. 2006 Aug;48(6):349-60.

PMID:
16872448
28.

H1 histamine receptor antagonists induce genotoxic and caspase-2-dependent apoptosis in human melanoma cells.

Jangi SM, Díaz-Pérez JL, Ochoa-Lizarralde B, Martín-Ruiz I, Asumendi A, Pérez-Yarza G, Gardeazabal J, Díaz-Ramón JL, Boyano MD.

Carcinogenesis. 2006 Sep;27(9):1787-96. Epub 2006 Mar 28.

PMID:
16569656
29.

Intracellular glutathione levels determine cell sensitivity to apoptosis induced by the antineoplasic agent N-(4-hydroxyphenyl) retinamide.

Morales MC, Pérez-Yarza G, Nieto-Rementeria N, Boyano MD, Jangi M, Atencia R, Asumendi A.

Anticancer Res. 2005 May-Jun;25(3B):1945-51.

30.

Structural and functional preservation of specific sequences of DNA and mRNA in apoptotic bodies from ES cells.

Andollo N, Boyano MD, Andrade R, Zalduendo MM, Eguizabal C, Asumendi A, Arlucea J, Aréchaga J.

Apoptosis. 2005 Mar;10(2):417-28.

PMID:
15843902
31.

Apoptosis of human T-cell acute lymphoblastic leukemia cells by diphenhydramine, an H1 histamine receptor antagonist.

Jangi SM, Asumendi A, Arlucea J, Nieto N, Perez-Yarza G, Morales MC, de la Fuente-Pinedo M, Boyano MD.

Oncol Res. 2004;14(7-8):363-72.

PMID:
15301427
32.

Effect of IL-2 and IL-6 on parameters related to metastatic activity in a murine melanoma.

García de Galdeano A, Cruz-Conde JC, Boyano MD, García-Vázquez MD, Cañavate ML.

Pathobiology. 2001;69(4):230-6.

PMID:
12007283
33.

Chromatin Structure and U2AF1-RS1 Gene Expression in Embryonic Stem Cells following RA-Induced Apoptosis.

Andollo N, Boyano MD, Garcia-Sanz M, Asumendi A, Zalduendo MM, Arechaga J.

ScientificWorldJournal. 2001 Nov 8;1:37. doi: 10.1100/tsw.2001.155. eCollection 2001. No abstract available.

34.

Interleukin-2 enhances the growth of human melanoma cells derived form primary but not from metastatic tumours.

García-Vázquez MD, Boyano MD, Cañavate ML, Gardeazabal J, de Galdeano AG, López-Michelena T, Ratón JA, Izu R, Díaz-Ramón JL, Díaz-Pérez JL.

Eur Cytokine Netw. 2000 Dec;11(4):654-61.

35.

Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.

Boyano MD, Garcia-Vázquez MD, López-Michelena T, Gardeazabal J, Bilbao J, Cañavate ML, Galdeano AG, Izu R, Díaz-Ramón L, Raton JA, Díaz-Pérez JL.

Br J Cancer. 2000 Oct;83(7):847-52.

36.

The role of cleavage of cell structures during apoptosis.

Asumendi A, Andollo N, Boyano MD, Hilario E, Perez-Yarza G, Atencia R, Arechaga J, García-Sanz M.

Cell Mol Biol (Noisy-le-grand). 2000 Feb;46(1):1-11.

PMID:
10726967
37.

Cyclosporin A upmodulates the alpha-subunit of the interleukin-2 receptor and the metastatic ability of murine B16F10 melanoma cells.

Boyano MD, de Galdeano AG, García-Vázquez MD, Alvarez A, Luz Cañavate M.

Invasion Metastasis. 1998-1999;18(3):122-33.

PMID:
10474025
38.

Serum-soluble IL-2 receptor and IL-6 levels in patients with melanoma.

Boyano MD, García-Vázquez MD, Gardeazabal J, García de Galdeano A, Smith-Zubiaga I, Cañavate ML, Raton JA, Bilbao I, Díaz-Pérez JL.

Oncology. 1997 Sep-Oct;54(5):400-6.

PMID:
9260602
39.

Parental chromosome-specific chromatin conformation in the imprinted U2af1-rs1 gene in the mouse.

Feil R, Boyano MD, Allen ND, Kelsey G.

J Biol Chem. 1997 Aug 15;272(33):20893-900.

40.

IL-2 treatment of B16F10 melanoma cells stimulates metastatic colonization in the liver.

Boyano MD, Garcia de Galdeano A, Smith-Zubiaga I, Cañavate ML.

Anticancer Res. 1997 Mar-Apr;17(2A):1135-41.

PMID:
9137461
41.

Serum interleukin-6 levels in patients with melanoma.

García-Vázquez MD, Díaz-Pérez JL, Gardeazabal J, Cañavate ML, García de Galdeano A, Smith-Zubiaga I, Boyano MD.

Int J Dev Biol. 1996;Suppl 1:305S-306S. No abstract available.

42.

Expression of IL-2 receptor beta-chain in B16 melanoma cells.

Garcia De Galdeano A, Boyano MD, Ayesta A, Alvarez MA, Smith-Zubiaga I, Garcia-Vazquez MD, Cañavate ML.

Int J Dev Biol. 1996;Suppl 1:301S-302S. No abstract available.

43.

B16F10 murine melanoma cells express interleukin-2 and a functional interleukin-2 receptor.

García de Galdeano A, Boyano MD, Smith-Zubiaga I, Cañavate ML.

Tumour Biol. 1996;17(3):155-67.

PMID:
8638089
44.

Enhancement of Ia antigen expression and nonproliferating cells correlates with metastatic capacity.

Boyano MD, Smith-Zubiaga I, Alvarez A, García de Galdeano A, Barberá-Guillem E, Cañavate ML.

Pathobiology. 1994;62(4):186-93.

PMID:
7734062
45.

Oncogene and MDR1 gene expression in rat rhabdomyosarcoma sublines of different metastatic potential.

Hanania N, Boyano MD, Mangin C, Poupon MF.

Anticancer Res. 1991 Jan-Feb;11(1):473-80.

PMID:
2018384
46.

Estimating anatomical-functional position coordinates in liver tissue.

Barberá-Guillem E, Alonso-Varona A, Boyano MD, Vidal-Vanaclocha F.

Anat Rec. 1990 Nov;228(3):267-76.

PMID:
2260782
47.

Coincident implantation, growth and interaction sites within the liver of cancer and reactive hematopoietic cells.

Vidal-Vanaclocha F, Alonso-Varona A, Ayala R, Boyano MD, Barberá-Guillem E.

Int J Cancer. 1990 Aug 15;46(2):267-71.

PMID:
2200755

Supplemental Content

Loading ...
Support Center